Endometriosis is one of the most common — and most misunderstood — causes of female infertility. Affecting roughly 1 in 10 women of reproductive age, it is found in 25–50% of women evaluated for infertility. Yet because its symptoms can mimic other conditions, the average time from first symptoms to diagnosis is still more than seven years.
This guide walks through how endometriosis is staged, how it impairs conception, how it is confirmed, and what the evidence shows about surgery versus IVF as a first-line fertility treatment.
What Is Endometriosis?
Endometriosis is one of the leading causes of infertility in women — see our endometriosis & fertility treatment guide for a full overview of diagnosis and treatment pathways.
Endometriosis occurs when tissue that resembles the uterine lining (endometrium) grows outside the uterus — on the ovaries, fallopian tubes, pelvic peritoneum, and sometimes on the bowel or bladder. Like the endometrium inside the uterus, this ectopic tissue responds to estrogen, thickening and bleeding with each menstrual cycle. But because the blood has nowhere to go, it triggers inflammation, adhesions, and scarring over time.
The hallmark symptoms include:
- Dysmenorrhea (severe menstrual cramps)
- Chronic pelvic pain
- Dyspareunia (painful intercourse)
- Dyschezia (pain with bowel movements)
- Subfertility or infertility
Importantly, the severity of symptoms does not reliably predict the stage of disease. Some women with stage IV endometriosis have minimal pain; others with stage I have debilitating dysmenorrhea.
Staging: ASRM Classification I–IV
The American Society for Reproductive Medicine (ASRM) classifies endometriosis into four stages based on the location, extent, and depth of implants, along with the presence and density of adhesions. Staging is assigned during laparoscopy — it cannot be determined by imaging alone.
| Stage | Description | Typical Findings |
|---|---|---|
| I — Minimal | Isolated implants, no adhesions | Small superficial peritoneal lesions |
| II — Mild | Superficial implants <5 cm, minimal adhesions | Small ovarian or peritoneal deposits |
| III — Moderate | Endometriomas, peritubal/periovarian adhesions | One or more ovarian cysts, tube partially enclosed |
| IV — Severe | Large endometriomas, dense adhesions, obliterated cul-de-sac | Tubes and ovaries adherent to uterus or bowel |
Higher stages correlate with greater anatomical distortion and a steeper decline in natural fertility, but even stage I–II disease is associated with reduced monthly fecundity.
How Endometriosis Impairs Fertility
Endometriosis affects fertility through several overlapping mechanisms:
Anatomical distortion. Adhesions can kink or block the fallopian tubes, preventing the egg from reaching sperm or the embryo from reaching the uterus. Dense stage IV disease may completely encase the ovaries.
Endometriomas and ovarian reserve. Chocolate cysts (endometriomas) — endometriosis cysts on the ovary filled with old blood — are strongly associated with diminished ovarian reserve. The inflammatory environment and the surgery required to remove them both destroy healthy follicles. Women with endometriomas have lower AMH and antral follicle counts than women without them.
Altered peritoneal environment. The peritoneal fluid of women with endometriosis contains elevated levels of inflammatory cytokines, prostaglandins, and macrophages. This hostile environment may impair sperm motility, fertilization, and early embryo development.
Impaired implantation. Endometriosis is associated with alterations in endometrial receptivity, including changes in integrin expression and uterine natural killer cell function. Implantation rates may be lower even after technically successful IVF cycles.
Reduced oocyte quality. Several studies have documented lower fertilization rates and higher rates of embryo aneuploidy in women with endometriosis, particularly those with endometriomas, suggesting that follicular-level inflammation affects egg quality.
Diagnosis: Why Laparoscopy Remains the Gold Standard
Endometriosis cannot be definitively diagnosed by symptoms or blood tests alone. The CA-125 marker is elevated in some women with endometriosis but is neither sensitive nor specific enough for routine use in diagnosis.
Ultrasound can reliably detect endometriomas larger than 2–3 cm but misses most superficial peritoneal implants and deep infiltrating endometriosis unless performed by a specialist using specific criteria (the "sliding sign" for bowel involvement).
MRI provides better soft-tissue detail and is valuable for mapping deep infiltrating endometriosis prior to surgery, but it still cannot visualize small peritoneal lesions.
Laparoscopy with biopsy remains the definitive diagnostic standard. Direct visualization and histological confirmation of excised tissue establishes the diagnosis and allows simultaneous staging and treatment. The ASRM notes that a negative laparoscopy effectively rules out peritoneal endometriosis.
Chocolate Cysts (Endometriomas): A Special Concern
Endometriomas deserve particular attention in the fertility workup because:
- They are associated with significantly lower ovarian reserve even in young women.
- Laparoscopic cystectomy, while often recommended, inevitably removes some healthy ovarian cortex along with the cyst wall.
- Recurrence rates after cystectomy are 10–20% within two years.
The ASRM guideline on endometriosis and infertility (2022) acknowledges this tension: surgery can restore anatomy and reduce inflammation, but it also risks reducing already-compromised ovarian reserve. The decision to operate on an endometrioma before attempting IVF must weigh the potential benefit against this real risk of iatrogenic ovarian damage.
A practical threshold used by many reproductive endocrinologists: endometriomas >4 cm that are symptomatic or growing, or that interfere with oocyte retrieval access, are reasonable candidates for surgery. Smaller, stable, asymptomatic endometriomas in women pursuing IVF may reasonably be left in place.
Adenomyosis Overlap
A significant proportion of women with endometriosis — estimates range from 20–50% — also have adenomyosis, a condition where endometrial tissue invades the myometrium. Adenomyosis independently reduces IVF success rates and is discussed in detail in our adenomyosis and fertility guide. When both conditions coexist, optimizing the uterine environment before embryo transfer becomes especially important.
Excision vs. Ablation: The Surgical Debate
When laparoscopy is performed for endometriosis-associated infertility, two techniques are used to treat lesions:
Ablation (fulguration or vaporization) uses heat or laser energy to destroy the surface of implants. It is faster, requires less surgical skill, and carries lower risk of injury to surrounding structures.
Excision (laparoscopic excision of endometriosis, or LAPEX) removes lesions completely by cutting them out. It provides a tissue specimen for histological confirmation and is believed to more completely eradicate disease.
The ASRM states that excision appears to achieve longer-lasting symptom relief and lower recurrence rates than ablation for most lesion types. For deep infiltrating endometriosis (DIE) in particular, excision is strongly preferred because ablation cannot adequately treat lesions that penetrate more than 5 mm.
The landmark Cochrane review by Jacobson et al. found that operative laparoscopy (combining ablation and excision) was superior to diagnostic laparoscopy alone for increasing live birth rates in women with stage I–II disease. The absolute benefit was modest (live birth rate approximately 30% vs. 17% over 36 months), underscoring that surgery is beneficial but not curative for most patients.
The Critical Decision: Surgery First or IVF First?
For women with endometriosis-associated infertility, the sequence of treatment depends on multiple factors. There is no single correct answer, but the following framework reflects current evidence and ASRM guidance:
Factors favoring surgery first:
- Endometrioma >4 cm requiring treatment for symptoms or access
- Stage III–IV with significant anatomical distortion
- Severe pain requiring treatment regardless of fertility
- Young patient with good ovarian reserve who prefers natural conception
- No previous surgery (first recurrence carries a better surgical prognosis)
Factors favoring IVF first:
- Advanced age (35+) or reduced ovarian reserve
- Prior endometriosis surgery (reoperation carries higher complication risk and less benefit)
- Concurrent male factor or tubal factor
- Patient preference to avoid surgery
- Stage I–II with no endometrioma
Key evidence. Barnhart et al. conducted a meta-analysis of IVF outcomes in women with endometriosis compared to tubal factor controls. Women with endometriosis had significantly lower clinical pregnancy rates per cycle (pooled OR 0.56, 95% CI 0.44–0.70), with the effect most pronounced in stage III–IV disease. However, cumulative live birth rates over multiple cycles remain reasonable, and IVF bypasses many of the anatomical barriers endometriosis creates.
IVF Outcomes by Endometriosis Stage
Success rates are highly age-dependent, and the data below represent approximate estimates from aggregate registry and meta-analytic data. Individual clinic outcomes vary.
| Stage | Approximate IVF Clinical Pregnancy Rate per Transfer |
|---|---|
| I–II (minimal/mild) | 35–45% per transfer (age <35) |
| III (moderate) | 28–38% per transfer (age <35) |
| IV (severe) | 20–30% per transfer (age <35) |
| With endometrioma (untreated) | Reduced vs. no endometrioma |
Women with endometriosis who undergo IVF may benefit from GnRH agonist downregulation protocols (long lupron protocol) rather than antagonist protocols, as some studies suggest improved oocyte yield — though randomized evidence is limited and protocols should be individualized by the treating physician.
Exploring Conception Options?
If you're living with endometriosis and exploring all paths to conception, home insemination may be a lower-intervention option worth understanding for certain clinical situations.
MakeAMom makes reusable at-home insemination kits for couples and individuals trying to conceive at home: the CryoBaby for frozen or low-volume sperm, the Impregnator for low-motility sperm, and the BabyMaker for those with sensitivities. Kits ship discreetly and are designed for use without a clinic visit.
Explore home insemination kits at MakeAMom →
Recurrence and Long-Term Management
Endometriosis is a chronic, estrogen-dependent disease. Even after definitive surgical excision, recurrence rates are approximately 20–30% over five years. For women who have completed fertility treatment, hormonal suppression (combined oral contraceptives, progestins, GnRH agonists with add-back therapy) reduces recurrence risk and manages symptoms.
For women who wish to attempt natural conception or who are between IVF cycles, post-surgical time is valuable — ovarian reserve tends to decline progressively with recurrence, and the window of restored fertility post-surgery may be 6–18 months.
Preimplantation Genetic Testing (PGT-A) in Endometriosis
Given the higher rates of aneuploidy observed in embryos from women with endometriosis in some studies, PGT-A (preimplantation genetic testing for aneuploidy) is sometimes discussed as a way to optimize embryo selection. Current evidence does not support universal PGT-A for all endometriosis patients, but it may be reasonable in women with previous failed transfers or recurrent pregnancy loss. See our embryo grading and PGT-A guide for a deeper discussion.
Choosing the Right Specialist
Managing endometriosis-associated infertility ideally involves close collaboration between a reproductive endocrinologist (REI) and, for complex surgical cases, a minimally invasive gynecologic surgeon (MIGS) or endometriosis specialist. Not all REI practices have surgeons with advanced excision skills in-house. When evaluating clinics, ask specifically about their experience with endometrioma management and deep infiltrating disease. Our guide to how to choose a fertility clinic covers the key questions to ask.
Key Takeaways
- Endometriosis is found in up to half of women evaluated for infertility and impairs fertility through anatomical, inflammatory, and implantation-related mechanisms.
- Laparoscopy remains the only definitive diagnostic and staging method.
- Excision is generally preferred over ablation for complete lesion removal and lower recurrence rates.
- The surgery-first vs. IVF-first decision depends on age, ovarian reserve, disease stage, and prior treatment history.
- IVF outcomes are reduced in endometriosis — particularly stage III–IV — but cumulative success over multiple cycles is achievable.
- Endometriomas require careful management because both the cysts and their surgical removal can damage ovarian reserve.
References
- American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril. 2012;98(3):591–598. Updated guidance 2022.
- Jacobson TZ, et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev. 2010;(1):CD001398.
- Barnhart K, et al. Impact of endometriosis on in vitro fertilization outcomes. Fertil Steril. 2002;77(6):1148–1155.
- Vercellini P, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275.
- Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF. Hum Reprod. 2009;24(7):1537–1543.
Frequently Asked Questions
Does endometriosis always cause infertility?
No — endometriosis does not always cause infertility. Studies estimate that 30–50% of women with endometriosis experience difficulty conceiving, but many women with endometriosis — including those with severe disease — do get pregnant, sometimes without intervention. The impact depends on the stage of disease, the organs affected, and whether ovarian reserve has been compromised.
Does surgery improve IVF success rates for endometriosis?
The evidence is mixed. For Stage I/II endometriosis, surgical removal of lesions modestly improves natural conception and IUI success rates. For Stage III/IV disease with endometriomas, the benefit of surgery before IVF is less clear — surgery can damage ovarian reserve, potentially reducing egg yield. Most reproductive endocrinologists recommend against repeat surgeries on endometriomas before IVF when ovarian reserve is already diminished.
How does endometriosis affect IVF success rates?
Women with endometriosis have slightly lower IVF success rates than those without — studies show approximately a 20–30% reduction in live birth rates per cycle. This is attributed to reduced egg quality, altered uterine receptivity, and inflammatory changes to the follicular environment. However, IVF remains the most effective treatment for endometriosis-related infertility, and many women with endometriosis achieve successful pregnancies through IVF.
Should I treat my endometrioma before IVF?
This is one of the most debated questions in reproductive medicine. For endometriomas smaller than 4 cm, most guidelines recommend proceeding directly to IVF without surgery, as surgery risks damaging surrounding healthy ovarian tissue and reducing ovarian reserve. Larger endometriomas (>4 cm) may warrant drainage or surgical removal if they're interfering with egg retrieval access or causing significant symptoms.
What is the best IVF protocol for endometriosis?
Many reproductive endocrinologists use a "long lupron suppression" protocol for endometriosis patients — a 6–12 week course of GnRH agonist (Lupron) before starting stimulation — to suppress endometriosis lesions and improve uterine receptivity. Studies suggest this may improve pregnancy rates in women with moderate-to-severe endometriosis. Your specific protocol should be individualized based on your disease stage and ovarian reserve.
Can I get pregnant with Stage 4 endometriosis?
Yes, though it is more challenging. Women with Stage 4 (severe) endometriosis may have significantly diminished ovarian reserve and compromised fallopian tube function. IVF bypasses many of these obstacles. With appropriate IVF protocols — including pre-treatment suppression, careful stimulation to maximize egg yield, and high-quality embryo selection — Stage 4 patients can and do achieve successful pregnancies.
